drugset / Trial / NCT04113096
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being done to find the effect of Dibenzyl Trisulphide (active ingredient in Guinea Hen Weed in combination in patients with stage four cancer of the breast, prostate, cervix and colon.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dibenzyl trisulphide | Unknown | 20 mg | — |